Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics Inc, filed a statement of changes in beneficial ownership on August 17, 2026, reporting a disposition of common stock on August 16, 2026, related to the vesting of previously granted restricted stock units.

Key Highlights

  • Reporting person: Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics Inc (NASDAQ:MYGN)
  • Transaction date: August 16, 2026, with the filing submitted on August 17, 2026
  • Shares withheld: 8,761 shares of common stock disposed of under transaction code F
  • Price per share: $3.03, described as the closing price of the issuer's common stock on August 14, 2026
  • Post-transaction ownership: Wheeler directly beneficially owned 289,748 shares of common stock following the reported transaction
  • Purpose of disposition: Shares were withheld by the issuer to satisfy tax withholding obligations connected to RSU vesting

Myriad Genetics CFO Wheeler: RSU Vesting Triggers Tax-Related Share Withholding

According to the filing, Myriad Genetics Inc, a molecular diagnostics company traded on NASDAQ under the symbol MYGN, withheld 8,761 shares of common stock from Chief Financial Officer Benjamin Richard Wheeler on August 16, 2026. The filing states that the withholding was made to satisfy tax obligations arising from the vesting of restricted stock units previously granted to Wheeler. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 14, 2026, which the filing records as $3.03 per share.

The transaction is coded as "F" in the filing, which under SEC reporting conventions denotes payment of an exercise price or tax liability by delivering or withholding securities. No shares were acquired by the reporting person in connection with this event. Following the withholding, Wheeler's direct beneficial ownership in Myriad Genetics common stock stood at 289,748 shares, as reported in Table I of the filing. No derivative securities transactions were reported in Table II. The filing was submitted by Justin Hunter on behalf of Benjamin R. Wheeler and is identified as a filing by one reporting person.

What Was Disclosed

The filing reported the withholding of 8,761 shares of Myriad Genetics common stock at $3.03 per share from CFO Benjamin Richard Wheeler on August 16, 2026, to cover tax obligations tied to restricted stock unit vesting, leaving him with direct ownership of 289,748 shares.